The Science, Art and Practice of Behavioural Medicine in MS: Amy B Sullivan PsyD ABPP

25 June, 2020 | Posted in:

2020 CMSC Virtual Annual Meeting Report by Denisse Bongol, MS Clinical Nurse Specialist, National Hospital for Neurology and Neurosurgery Aims of the session Amy Sullivan shared a series of learning objectives from the session, which were to: Examine the cost of chronic diseases and mental health issues in the general population, Improve ability to assess and understand […]

Continue Reading »

DMT safety issues – EAN 2020

24 June, 2020 | Posted in:

EAN Congress 2020 Joela Mathews, Lead Neuroscience Pharmacist for Barts Health NHS Trust and Rachel Dorsey-Campbell, Senior Lead Pharmacist, Neurosciences, Imperial College Healthcare NHS Trust, discussed some of their highlights from the EAN 2020 focussing on drug safety. Alemtuzumab safety (0.39) Rachel outlined a poster session on the safety of alemtuzumab over a nine year period […]

Continue Reading »

Webinar: New service models

23 June, 2020 | Posted in:

Please note that all session and slide content are the views of the Speakers, not the MS Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change. CPD acceditation This webinar has been approved […]

Continue Reading »

The importance of assessing nutritional health in patients with multiple sclerosis: Mona Bostick, RDN LDN

23 June, 2020 | Posted in: ,

2020 CMSC Virtual Annual Meeting Report by Amy Harbour, Multiple Sclerosis Nurse Specialist and clinical lead (South East Hants), Southern Health NHS Foundation Trust. Aims of the session The aims of this article are to:  Define the role of health literacy and food literacy in health outcomes Review tools to facilitate nutritional conversations with people […]

Continue Reading »

Caring for Women Across the Reproductive Lifespan: Riley Bove, MD

22 June, 2020 | Posted in:

2020 CMSC Virtual Annual Meeting The Consortium of Multiple Sclerosis Centers (CMSC) Virtual Annual Meeting took place between Tuesday 26th and Friday 29th May 2020. The packed programme was available to attend online, and several of MS Academy faculty, and MS specialist nurses associated with the Academy, attended the sessions.  They have each produced a […]

Continue Reading »

Cannabis and MS – Efficacy, Safety, Drug Interactions and Research Update: Allen Bowling, MD PhD

19 June, 2020 | Posted in:

2020 CMSC Virtual Annual Meeting Report by Sarah Gibbs, MS Specialist Nurse, Solent NHS Trust The Consortium of Multiple Sclerosis Centers (CMSC) Virtual Annual Meeting took place between Tuesday 26th and Friday 29th May 2020. The packed programme was available to attend online, and several of MS Academy faculty, and MS specialist nurses associated with the […]

Continue Reading »

Comorbidities and MS: Patricia Melville, NP-C

17 June, 2020 | Posted in:

2020 CMSC Virtual Annual Meeting Report by Amy Harbour, Multiple Sclerosis Nurse Specialist and clinical lead (South East Hants), Southern Health NHS Foundation Trust. Aims of the session (0:21) The aims of this piece are to:  Identify common comorbidities in MS Examine the importance of comorbidities in MS Use critical thinking in management of comorbidities […]

Continue Reading »

Patients as partners – raising the bar for MS during COVID-19

16 June, 2020 | Posted in: ,

As with all of the work taking place to improve MS services at present, the coronavirus pandemic has amplified the needs addressed by the Patients as Partners workstream.  Shift.ms have stated concisely that: ‘Those dealing with diagnosis and disease management are now doing so with reduced social support and face-to-face time with clinical teams. Health […]

Continue Reading »

‘The Forgotten Many’ reports on significant service gaps for people with secondary progressive MS

15 June, 2020 | Posted in: ,

A new report has been released today which shines a light on the significant gaps that currently exist across the NHS in Secondary Progressive Multiple Sclerosis (SPMS) policy, service provision and patient care.  Developed by Wilmington Healthcare and funded by Novartis, the report, ‘The Forgotten Many: A 2020 Vision for Secondary Progressive Multiple Sclerosis’, has […]

Continue Reading »